These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36963629)

  • 1. Microbiome and Retinal Vascular Diseases.
    Lincke JB; Christe L; Unterlauft JD; Zinkernagel MS; Zysset-Burri DC
    Am J Pathol; 2023 Nov; 193(11):1675-1682. PubMed ID: 36963629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota and Heart, Vascular Injury.
    Zeng C; Tan H
    Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship.
    Nesci A; Carnuccio C; Ruggieri V; D'Alessandro A; Di Giorgio A; Santoro L; Gasbarrini A; Santoliquido A; Ponziani FR
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut microbiota in retinal diseases.
    Bringer MA; Gabrielle PH; Bron AM; Creuzot-Garcher C; Acar N
    Exp Eye Res; 2022 Jan; 214():108867. PubMed ID: 34856206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome and retinal diseases: an updated review.
    Nadeem U; Boachie-Mensah M; Zhang J; Skondra D
    Curr Opin Ophthalmol; 2022 May; 33(3):195-201. PubMed ID: 35132003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota and metabolites in diabetic retinopathy: Insights into pathogenesis for novel therapeutic strategies.
    Cai Y; Kang Y
    Biomed Pharmacother; 2023 Aug; 164():114994. PubMed ID: 37301133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between diet, the gut microbiome, and atherosclerosis: Role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism.
    Anto L; Blesso CN
    J Nutr Biochem; 2022 Jul; 105():108991. PubMed ID: 35331903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota revolution: How gut microbes regulate our lives.
    Colella M; Charitos IA; Ballini A; Cafiero C; Topi S; Palmirotta R; Santacroce L
    World J Gastroenterol; 2023 Jul; 29(28):4368-4383. PubMed ID: 37576701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjusting for age improves identification of gut microbiome alterations in multiple diseases.
    Ghosh TS; Das M; Jeffery IB; O'Toole PW
    Elife; 2020 Mar; 9():. PubMed ID: 32159510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders.
    Sankararaman S; Noriega K; Velayuthan S; Sferra T; Martindale R
    Curr Gastroenterol Rep; 2023 Feb; 25(2):31-44. PubMed ID: 36469257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders.
    Rajani C; Jia W
    Clin Sci (Lond); 2018 Apr; 132(7):791-811. PubMed ID: 29661926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome.
    Abenavoli L; Scarlata GGM; Scarpellini E; Boccuto L; Spagnuolo R; Tilocca B; Roncada P; Luzza F
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings.
    Das BK
    APMIS; 2022 Dec; 130(12):719-740. PubMed ID: 36321381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the gut microbiome in eye diseases.
    Zysset-Burri DC; Morandi S; Herzog EL; Berger LE; Zinkernagel MS
    Prog Retin Eye Res; 2023 Jan; 92():101117. PubMed ID: 36075807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease.
    El Hage R; Al-Arawe N; Hinterseher I
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease.
    Sultan S; El-Mowafy M; Elgaml A; Ahmed TAE; Hassan H; Mottawea W
    Front Physiol; 2021; 12():715506. PubMed ID: 34646151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.